Nath Bio-Genes (India) Live BSE/NSE | Nath Bio-Genes (India) Fundamenta data | Nath Bio-Genes (India) Balance sheet | Nath Bio-Genes (India) Quarterly Results | Nath Bio-Genes (India) Profit & Loss

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

599.39
10.61
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

647.56
N/A
1.00

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

10.80
11.54
13.46

EBITDA CAGR (%)

10 Years
5 Years
3 Years

15.17
17.33
6.26

PAT CAGR (%)

10 Years
5 Years
3 Years

20.29
28.93
19.72

P:E (Median)

8 Years
5 Years
3 Years

-
19.99
20.57

P:BV (Average)

8 Years
5 Years
3 Years

-
0.98
0.98

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
14.96
16.57

Quarterly Results

Standalone Figures in Rs. Crores

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 194 166 17% 61 52 16% 33 28 19% 22 25 -12%
Expenses 149 128 16% 53 47 15% 27 22 25% 16 19 -14%
EBITDA 44 38 18% 7 6 24% 6 6 -5% 6 6 -5%
EBIDTM 23% 23% 0% 11% 17% 21% 26% 24%
Other Income 0 0 0 0 0 -100% 0 0 -3% 0 0 0
Interest 2 2 14% 2 1 25% 2 2 -6% 1 2 -26%
Depreciation 1 0 91% 0 0 -12% 0 0 9% 0 0 9%
PBT 42 35 17% 5 4 15% 4 4 -5% 4 4 5%
Tax 0 0 43% -2 -1 - 0 1 -79% 0 0 0
PAT 41 35 17% 8 6 39% 4 4 11% 4 4 2%
PATM 21% 21% 3% 11% 12% 13% 17% 15%
EPS 21.71 18.56 17% 4.02 2.90 39% 2.05 1.84 11% 1.94 1.90 2%

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 0 0 0 0 0 0 0 0 0 0 0 0
Expenses 0 0 0 0 0 0 0 0 0 0 0 0
EBITDA 0 0 0 0 0 0 0 0 0 0 0 0
EBIDTM 0% 0% 0% 0% 0% 0% 0% 0%
Other Income 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
PBT 0 0 0 0 0 0 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0
PAT 0 0 0 0 0 0 0 0 0 0 0 0
PATM 0% 0% 0% 0% 0% 0% 0% 0%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 309 280 231 192 170 162 185 172 138 124 100 Net Sales Growth 14% 21% 20% 13% 5% -13% 8% 25% 11% 23% Cost Of Goods Sold 609 -41 -25 10 12 -20 -26 0 -2 4 9 Gross Profit -299 321 256 182 158 182 211 172 140 120 92 GP Margin -97% 115% 111% 95% 93% 112% 114% 100% 101% 97% 91% Total Expenditure 246 225 188 151 141 137 151 138 118 109 87 Power & Fuel Cost - 1 1 1 1 1 1 1 0 0 0 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Employee Cost - 19 16 12 14 14 16 13 10 9 6 % Of Sales - 7% 7% 6% 8% 8% 8% 8% 7% 7% 6% Manufacturing Exp. - 180 143 87 69 88 99 73 64 55 40 % Of Sales - 64% 62% 45% 41% 54% 54% 42% 46% 45% 40% General & Admin Exp. - 19 17 11 7 7 6 6 5 4 3 % Of Sales - 7% 7% 6% 4% 5% 3% 3% 3% 3% 3% Selling & Distn. Exp. - 46 34 28 36 47 54 46 39 34 27 % Of Sales - 16% 15% 15% 21% 29% 29% 26% 28% 28% 26% Miscellaneous Exp. - 1 1 2 2 1 1 0 1 2 27 % Of Sales - 1% 1% 1% 1% 1% 0% 0% 1% 2% 1% EBITDA 63 55 43 40 29 25 35 34 20 15 13 EBITDA Margin 20% 20% 19% 21% 17% 15% 19% 20% 14% 12% 13% Other Income 0 2 2 1 1 1 1 1 1 1 1 Interest 7 7 5 10 10 6 5 4 4 2 2 Depreciation 2 1 1 1 3 4 4 5 5 5 5 PBT 55 49 39 30 17 15 26 26 12 9 8 Tax -2 -2 0 1 0 1 1 1 1 0 0 Tax Rate -3% -4% 1% 2% 3% 6% 4% 5% 4% -1% -4% PAT 56 50 38 29 16 14 25 24 12 9 8 PAT before Minority Interest 56 50 38 29 16 14 25 24 12 9 8 Minority Interest 0 0 0 0 0 0 0 0 0 0 0 PAT Margin 18% 18% 17% 15% 10% 9% 14% 14% 9% 7% 8% PAT Growth 18% 31% 31% 81% 15% -44% 5% 107% 28% 16% EPS 29.73 26.57 20.23 15.48 8.57 7.46 13.37 12.79 6.18 4.84 4.19

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Net Sales

309

280

231

192

170

162

185

172

138

124

100

Net Sales Growth

14%

21%

20%

13%

-13%

25%

11%

23%

Cost Of Goods Sold

609

-41

-25

-20

-26

-2

Gross Profit

-299

321

256

182

158

182

211

172

140

120

GP Margin

-97%

115%

111%

95%

93%

112%

114%

100%

101%

97%

91%

Total Expenditure

246

225

188

151

141

137

151

138

118

109

Power & Fuel Cost

% Of Sales

Employee Cost

% Of Sales

Manufacturing Exp.

180

143

% Of Sales

64%

62%

45%

41%

54%

42%

46%

45%

40%

General & Admin Exp.

% Of Sales

Selling & Distn. Exp.

% Of Sales

16%

15%

21%

29%

26%

28%

26%

Miscellaneous Exp.

% Of Sales

EBITDA

EBITDA Margin

20%

19%

21%

17%

15%

19%

20%

14%

12%

13%

Other Income

Interest

Depreciation

PBT

Tax

-2

Tax Rate

-3%

-4%

-1%

-4%

PAT

PAT before Minority Interest

Minority Interest

PAT Margin

18%

17%

15%

10%

14%

PAT Growth

18%

31%

81%

15%

-44%

107%

28%

16%

EPS

29.73

26.57

20.23

15.48

8.57

7.46

13.37

12.79

6.18

4.84

4.19

Description TTM Mar 13 Mar 12
Net Sales - 138 124 Net Sales Growth - 11% Cost Of Goods Sold - -2 4 Gross Profit - 140 120 GP Margin - 101% 97% Total Expenditure - 118 109 Power & Fuel Cost - 0 0 % Of Sales - 0% 0% Employee Cost - 10 9 % Of Sales - 7% 7% Manufacturing Exp. - 66 55 % Of Sales - 48% 45% General & Admin Exp. - 5 4 % Of Sales - 3% 3% Selling & Distn. Exp. - 37 34 % Of Sales - 27% 28% Miscellaneous Exp. - 1 2 % Of Sales - 1% 2% EBITDA - 20 15 EBITDA Margin - 14% 12% Other Income - 1 1 Interest - 4 2 Depreciation - 5 5 PBT - 12 9 Tax - 1 0 Tax Rate - 4% -1% PAT - 12 9 PAT before Minority Interest - 12 9 Minority Interest - 0 0 PAT Margin - 9% 7% PAT Growth - 28% EPS - 6.18 4.84

Description

TTM

Mar 13

Mar 12

Net Sales

138

124

Net Sales Growth

11%

Cost Of Goods Sold

-2

Gross Profit

140

120

GP Margin

101%

97%

Total Expenditure

118

109

Power & Fuel Cost

% Of Sales

Employee Cost

% Of Sales

Manufacturing Exp.

% Of Sales

48%

45%

General & Admin Exp.

% Of Sales

Selling & Distn. Exp.

% Of Sales

27%

28%

Miscellaneous Exp.

% Of Sales

EBITDA

EBITDA Margin

14%

12%

Other Income

Interest

Depreciation

PBT

Tax

Tax Rate

-1%

PAT

PAT before Minority Interest

Minority Interest

PAT Margin

PAT Growth

28%

EPS

6.18

4.84

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 558 508 469 303 121 107 82 57 46 37 Share Capital 19 19 19 16 16 16 16 16 16 6 Total Reserves 539 489 450 287 105 91 66 41 30 21 Non-Current Liabilities 2 2 1 21 16 2 2 2 1 2 Secured Loans 0 0 0 20 15 1 1 1 1 1 Unsecured Loans 0 0 0 0 0 0 0 0 0 0 Long Term Provisions 2 2 2 2 2 2 2 1 1 1 Current Liabilities 174 139 100 130 129 116 105 83 72 63 Trade Payables 68 50 37 44 48 52 39 27 16 13 Other Current Liabilities 29 28 28 34 35 43 46 39 47 44 Short Term Borrowings 70 57 32 49 43 20 20 16 8 6 Short Term Provisions 8 3 3 3 2 1 0 0 0 0 Total Liabilities 734 648 570 454 266 225 189 142 119 102 Net Block 246 232 211 207 30 13 17 18 21 23 Gross Block 265 250 228 224 82 61 17 58 56 23 Accumulated Depreciation 19 18 17 16 52 48 0 39 35 0 Non Current Assets 252 238 216 212 41 27 30 23 23 25 Capital Work in Progress 0 0 0 0 0 0 0 0 0 0 Non Current Investment 5 5 5 5 0 0 0 5 1 0 Long Term Loans & Adv. 1 1 0 0 10 15 13 0 2 2 Other Non Current Assets 0 0 0 0 0 0 0 0 0 0 Current Assets 482 410 354 242 225 198 159 119 96 77 Current Investments 0 0 0 0 5 5 5 0 0 0 Inventories 204 155 123 130 141 117 89 77 66 64 Sundry Debtors 107 108 82 52 45 45 35 21 12 8 Cash & Bank 22 21 45 6 1 2 2 2 3 1 Other Current Assets 149 4 2 1 33 29 28 18 15 5 Short Term Loans & Adv. 142 121 103 53 32 28 27 17 14 4 Net Current Assets 308 271 254 112 97 81 54 36 24 14 Total Assets 734 648 570 454 266 225 189 142 119 102

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Shareholder's Funds

558

508

469

303

121

107

Share Capital

Total Reserves

539

489

450

287

105

Non-Current Liabilities

Secured Loans

Unsecured Loans

Long Term Provisions

Current Liabilities

174

139

100

130

129

116

105

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Liabilities

734

648

570

454

266

225

189

142

119

102

Net Block

246

232

211

207

Gross Block

265

250

228

224

Accumulated Depreciation

Non Current Assets

252

238

216

212

Capital Work in Progress

Non Current Investment

Long Term Loans & Adv.

Other Non Current Assets

Current Assets

482

410

354

242

225

198

159

119

Current Investments

Inventories

204

155

123

130

141

117

Sundry Debtors

107

108

Cash & Bank

Other Current Assets

149

Short Term Loans & Adv.

142

121

103

Net Current Assets

308

271

254

112

Total Assets

734

648

570

454

266

225

189

142

119

102

Description Mar 13 Mar 12
Shareholder's Funds 57 46 Share Capital 16 16 Total Reserves 41 30 Non-Current Liabilities 2 1 Secured Loans 1 1 Unsecured Loans 0 0 Long Term Provisions 1 1 Current Liabilities 98 72 Trade Payables 28 16 Other Current Liabilities 53 47 Short Term Borrowings 17 8 Short Term Provisions 0 0 Total Liabilities 157 119 Net Block 38 21 Gross Block 77 56 Accumulated Depreciation 39 35 Non Current Assets 38 23 Capital Work in Progress 0 0 Non Current Investment 0 1 Long Term Loans & Adv. 0 2 Other Non Current Assets 0 0 Current Assets 120 96 Current Investments 0 0 Inventories 77 66 Sundry Debtors 21 12 Cash & Bank 2 3 Other Current Assets 19 0 Short Term Loans & Adv. 17 14 Net Current Assets 22 24 Total Assets 157 119

Description

Mar 13

Mar 12

Shareholder's Funds

Share Capital

Total Reserves

Non-Current Liabilities

Secured Loans

Unsecured Loans

Long Term Provisions

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Liabilities

157

119

Net Block

Gross Block

Accumulated Depreciation

Non Current Assets

Capital Work in Progress

Non Current Investment

Long Term Loans & Adv.

Other Non Current Assets

Current Assets

120

Current Investments

Inventories

Sundry Debtors

Cash & Bank

Other Current Assets

Short Term Loans & Adv.

Net Current Assets

Total Assets

157

119

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Cash From Operating Activity 9 -23 -47 3 -14 6 15 1 0 PBT 49 39 30 17 15 26 26 12 0 Adjustment 7 5 10 13 10 9 8 8 0 Changes in Working Capital -45 -64 -87 -26 -39 -28 -18 -19 0 Cash after chg. in Working capital 11 -20 -47 3 -14 7 16 1 0 Interest Paid 0 0 0 0 0 0 0 0 0 Tax Paid -2 -3 0 0 0 -1 -1 -1 0 Other Direct Exp. Paid 0 0 0 0 0 0 0 0 0 Extra & Other Items 0 0 0 0 0 0 0 0 0 Cash From Investing Activity -14 -20 -4 -4 -17 -2 -16 -7 0 Net Fixed Assets -15 -22 -4 -142 -21 -44 41 -2 Net Investments 0 0 0 0 0 0 0 -4 Others 1 1 0 138 4 42 -57 0 Cash from Financing Activity 6 20 90 5 30 -4 1 5 0 Net Cash Inflow / Outflow 1 -23 39 5 0 -1 0 -1 0 Opening Cash & Equivalents 21 45 6 1 2 2 2 3 0 Closing Cash & Equivalent 22 21 45 6 1 2 2 2 0

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Cash From Operating Activity

-23

-47

-14

PBT

Adjustment

Changes in Working Capital

-45

-64

-87

-26

-39

-28

-18

-19

Cash after chg. in Working capital

-20

-47

-14

Interest Paid

Tax Paid

-2

-3

-1

Other Direct Exp. Paid

Extra & Other Items

Cash From Investing Activity

-14

-20

-4

-17

-2

-16

-7

Net Fixed Assets

-15

-22

-4

-142

-21

-44

-2

Net Investments

-4

Others

138

-57

Cash from Financing Activity

-4

Net Cash Inflow / Outflow

-23

-1

Opening Cash & Equivalents

Closing Cash & Equivalent

Description Mar 13 Mar 12
Cash From Operating Activity 14 0 PBT 12 0 Adjustment 8 0 Changes in Working Capital -6 0 Cash after chg. in Working capital 15 0 Interest Paid 0 0 Tax Paid -1 0 Other Direct Exp. Paid 0 0 Extra & Other Items 0 0 Cash From Investing Activity -21 0 Net Fixed Assets -2 Net Investments -4 Others -15 Cash from Financing Activity 6 0 Net Cash Inflow / Outflow -1 0 Opening Cash & Equivalents 3 0 Closing Cash & Equivalent 2 0

Description

Mar 13

Mar 12

Cash From Operating Activity

PBT

Adjustment

Changes in Working Capital

-6

Cash after chg. in Working capital

Interest Paid

Tax Paid

-1

Other Direct Exp. Paid

Extra & Other Items

Cash From Investing Activity

-21

Net Fixed Assets

-2

Net Investments

-4

Others

-15

Cash from Financing Activity

Net Cash Inflow / Outflow

-1

Opening Cash & Equivalents

Closing Cash & Equivalent

Financial Ratios

Standalone /

Consolidated

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 293 267 247 190 76 67 51 36 29 42 ROA 7% 6% 6% 5% 6% 12% 15% 9% 8% 8% ROE 9% 8% 8% 8% 12% 27% 35% 23% 25% 30% ROCE 9% 8% 9% 10% 14% 26% 33% 24% 20% 19% Fixed Asset Turnover 1.09 0.97 0.85 1.11 2.27 4.80 4.65 2.43 3.13 4.31 Receivable days 140 150 127 104 102 79 60 44 30 28 Inventory Days 235 220 242 291 290 202 176 189 191 232 Payable days 103 91 105 133 130 112 85 67 50 199 Cash Conversion Cycle 271 280 264 263 262 169 150 167 170 61 Total Debt/Equity 0.13 0.11 0.07 0.24 0.48 0.21 0.28 0.32 0.25 0.49 Interest Cover 8 8 4 3 3 7 7 4 6 5

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Book Value (Rs.)

293

267

247

190

ROA

12%

15%

ROE

12%

27%

35%

23%

25%

30%

ROCE

10%

14%

26%

33%

24%

20%

19%

Fixed Asset Turnover

1.09

0.97

0.85

1.11

2.27

4.80

4.65

2.43

3.13

4.31

Receivable days

140

150

127

104

102

Inventory Days

235

220

242

291

290

202

176

189

191

232

Payable days

103

105

133

130

112

199

Cash Conversion Cycle

271

280

264

263

262

169

150

167

170

Total Debt/Equity

0.13

0.11

0.07

0.24

0.48

0.21

0.28

0.32

0.25

0.49

Interest Cover

Description Mar 13 Mar 12
Book Value (Rs.) 36 29 ROA 8% 8% ROE 23% 20% ROCE 24% 19% Fixed Asset Turnover 2.08 2.22 Receivable days 44 37 Inventory Days 189 194 Payable days 67 56 Cash Conversion Cycle 167 174 Total Debt/Equity 0.33 0.25 Interest Cover 4 6

Nath Bio-Genes (India) Ltd.

Agriculture

BSE: 537291 | NSE: NATHBIOGEN

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Annual Reports:

News Update

Nath Bio-Genes (India) Ltd.

Agriculture

BSE: 537291 | NSE: NATHBIOGEN

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Annual Reports:

News Update